# Pfizer Inc. (PFE) — Q2-2013 Earnings Results

**Report date:** 2013-07-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2013

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 0.44%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.56 | N/A | +3.32% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their current projects and emphasized the need for continued innovation. They are focused on navigating market challenges.

**Key quotes:**

> Management highlighted ongoing efforts in research and development.

> They noted the importance of maintaining strong operational efficiency.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Pfizer's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The lack of revenue data and guidance may leave some investors cautious. Overall, the company appears to be on a stable path, but further clarity on future performance is needed.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2013_